기업 정보 불러오는 중
Just reported
Q3 2026 results
From Merck's results release of 2026년 10월 29일; its quarterly report has since been filed.
Revenue
Actual
US$18.09B
+4.7% y/y
+8.9% q/qGuided
—
No guide given
EPS, GAAP
Actual
US$2.04
-12% y/y
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
The full earnings report →Keep exploring
The themes Merck is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The themes it is part of
Highest-graded in Drug Manufacturers General
Graded A or B and worth $2B or more: A first, then the largest.
LLYELI Lilly And CompanyUS$1.35TA+
JNJJohnson & JohnsonUS$682.6BA+
NVSNovartis AGUS$305.8BA
AMGNAmgen Inc.US$252.6BA+
GILDGilead Sciences, Inc.US$208.3BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation2026년 10월 21일CBGraded C, now B
MCKMckesson Corporation2026년 11월 4일BAGraded B, now A
CVSCVS Health Corp2026년 11월 4일BAGraded B, now A
EWEdwards Lifesciences Corporation2026년 11월 4일BAGraded B, now A
BIIBBiogen Inc.2026년 10월 28일BAGraded B, now A
어떻게 돈을 버는가
- Human medicines and vaccines (Pharmaceutical segment)90%
- Animal medicines, vaccines and related products (Animal Health segment)10%
매출 비중은 FY2025 기준 추정치이며, 제출된 보고서의 수치가 아닙니다.
경쟁 상대
무엇을 파는가6
Keytruda and Keytruda Qlex
Cancer medicines. Keytruda is given into a vein; Keytruda Qlex is a form given as an injection under the skin.
Gardasil and Gardasil 9
Vaccines that help prevent certain cancers and other diseases caused by some types of human papillomavirus.
Januvia and Janumet
Prescription medicines used to help lower blood sugar in adults with type 2 diabetes.
3개 더 보기
Winrevair
A medicine for adults with pulmonary arterial hypertension, a disease that raises blood pressure in the arteries from the heart to the lungs.
Lipfendra
An oral medicine used with diet and exercise to lower low-density lipoprotein cholesterol in adults with high cholesterol.
Bravecto
A range of medicines that protect dogs and cats against fleas and ticks, including oral, topical and injectable forms.
누가 사는가5
- Drug wholesalers and retailers buy Merck's human prescription medicines for distribution to pharmacies and other care providers.
- Hospitals, government agencies and managed health-care organizations buy or arrange access to prescription medicines.
- Physicians, wholesalers, distributors and government entities buy or distribute Merck's human vaccines.
2개 더 보기
- Veterinarians, animal-health distributors, animal producers and farmers buy veterinary medicines, vaccines and animal monitoring products.
- Pet owners buy Merck's companion-animal products, sometimes through veterinary practices or distributors.
무엇에 기대고 있고, 무엇이 무너뜨릴 수 있는가
사업이 기대고 있는 것
- 1Sales depend heavily on a small number of major medicines. Keytruda was Merck's biggest-selling product in 2025, and sales depend on continued demand, market access and patent protection.
- 2Merck depends on patents and other legal protections for medicines. When products lose market exclusivity, generic or biosimilar versions can take sales; the 2026 quarterly report describes this pressure on Januvia, Janumet and Bridion.
- 3Sales depend on regulatory approval, health-care coverage and government and insurer purchasing decisions. The company also reports that certain raw or intermediate materials come primarily from a single supplier.
- 4Gardasil sales in China depend on demand and the relationship with its Chinese distributor and commercialization partner; Merck suspended shipments in 2025 and resumed limited shipments in 2026.
잘못될 수 있는 일
- 1Merck identifies its dependence on patent rights as a risk: if patents are invalidated or products lose market exclusivity, generic or biosimilar competition can rapidly reduce sales. Keytruda is its biggest-selling product, and the company reports that U.S. government price-setting for certain medicines is also affecting its business.
- 2Government and private health-care cost controls can lower prices or restrict access. The latest quarterly report describes price-setting, Medicaid discounts and other cost-reduction measures, including a German health-care reform law expected to put downward pressure on sales there.
- 3Vaccine sales can be affected by changes in vaccination recommendations, government purchasing and demand. Gardasil sales fell in China, where Merck suspended shipments before agreeing to limited shipments under a revised distributor contract; U.S. childhood immunization schedule changes were also subject to a court injunction and government appeal.
Merck & Co., Inc. 소개
Merck discovers, develops, manufactures and sells prescription medicines and vaccines for people, including cancer treatments such as Keytruda and vaccines such as Gardasil. Its Animal Health business sells medicines, vaccines and animal identification and monitoring products to veterinarians, farmers and other animal-care businesses.
- 본사
- Rahway, New Jersey, United States
- 설립
- 1891
- 상장 시장
- NYSE
- 회계연도 종료
- December 31
Merck & Co., Inc.이(가) 미국 증권거래위원회(SEC)에 직접 제출한 공시로 만들었습니다. 수치는 보고된 그대로이며, 주당 이력은 오늘의 주식 수 기준으로 재계산했습니다. 이것은 사업을 설명하는 자료입니다. 투자 자문이 아니며 어떤 매수나 매도도 권유하지 않습니다.